Literature DB >> 1331974

The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid.

H Brinkmeier1, K H Wollinsky, P J Hülser, M J Seewald, H H Mehrkens, H H Kornhuber, R Rüdel.   

Abstract

The effect of cerebrospinal fluid (CSF) from patients with severe polyradiculoneuritis (Guillain-Barré syndrome, GBS) on voltage-dependent Na+ channels of myoballs was studied. The transient Na+ currents, elicited by repetitive stimulation at 1 Hz, were inhibited by the CSF from most of the GBS patients to 10%-40% the control value. The inhibition was complete in about 5 s and was fully reversible. Such inhibition was never seen with control CSF. The blocking property of the CSF from GBS patients was lost after the number of cells and the protein content had been lowered by means of a clinical filtration technique for cerebrospinal fluid. The results demonstrate that in Guillain-Barré syndrome blocking factors of Na+ channels are present in the CSF, impairing neuron impulse conduction, and thereby causing muscular weakness and sensory disturbances in the affected patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331974     DOI: 10.1007/bf00375050

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  15 in total

Review 1.  T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome.

Authors:  H P Hartung; K V Toyka
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

2.  A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.

Authors:  T Kanda; H Hayashi; H Tanabe; T Tsubaki; M Oda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

3.  Cultivation, morphology, and electrophysiology of contractile rat myoballs.

Authors:  S Boldin; U Jäger; J P Ruppersberg; S Pentz; R Rüdel
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

4.  Patterns of conduction failure in the Guillain-Barré syndrome.

Authors:  F G van der Meché; J Meulstee; M Vermeulen; A Kievit
Journal:  Brain       Date:  1988-04       Impact factor: 13.501

5.  Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients.

Authors:  G Frampton; J B Winer; J S Cameron; R A Hughes
Journal:  J Neuroimmunol       Date:  1988-08       Impact factor: 3.478

6.  Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders.

Authors:  M Weller; A Stevens; N Sommer; A Melms; J Dichgans; H Wiethölter
Journal:  J Neurol Sci       Date:  1991-08       Impact factor: 3.181

7.  Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.

Authors:  S Rudnicki; F Vriesendorp; C L Koski; R F Mayer
Journal:  Muscle Nerve       Date:  1992-01       Impact factor: 3.217

8.  Guillain-Barré syndrome: activated complement components C3a and C5a in CSF.

Authors:  H P Hartung; C Schwenke; D Bitter-Suermann; K V Toyka
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

Review 9.  Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features.

Authors:  J W Albers; J J Kelly
Journal:  Muscle Nerve       Date:  1989-06       Impact factor: 3.217

10.  Liquorpheresis (CSF-filtration): an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barré syndrome).

Authors:  K H Wollinsky; M Weindler; P J Hülser; P Geiger; N Matzek; H H Mehrkens; H H Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

View more
  8 in total

1.  Neurological channelopathies.

Authors:  M R Rose
Journal:  BMJ       Date:  1998-04-11

Review 2.  Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Authors:  Jane Pritchard; Richard Ac Hughes; Robert Dm Hadden; Ruth Brassington
Journal:  Cochrane Database Syst Rev       Date:  2016-11-15

3.  Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.

Authors:  Yoshihiko Nakatani; Sayako Hotta; Iku Utsunomiya; Keiko Tanaka; Keiko Hoshi; Toshi Ariga; Robert K Yu; Tadashi Miyatake; Kyoji Taguchi
Journal:  Neurochem Res       Date:  2008-05-14       Impact factor: 3.996

4.  Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line.

Authors:  R Barrett-Jolley; N Byrne; A Vincent; J Newsom-Davis
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

5.  Local anaesthetic-like effect of interleukin-2 on muscular Na+ channels: no evidence for involvement of the IL-2 receptor.

Authors:  A Kaspar; H Brinkmeier; R Rüdel
Journal:  Pflugers Arch       Date:  1994-01       Impact factor: 3.657

6.  Serine-1321-independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase C.

Authors:  S Bendahhou; T R Cummins; J F Potts; J Tong; W S Agnew
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

7.  Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Authors:  Alex Y Doets; Richard Ac Hughes; Ruth Brassington; Robert Dm Hadden; Jane Pritchard
Journal:  Cochrane Database Syst Rev       Date:  2020-01-25

8.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.